Supriya Lifescience Limited - Due diligence report
A 360° intelligence report on Supriyalifescience: trust score, financial health, credit view, compliance, directors, growth and distress sig…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Supriyalifescience — 360° Intelligence Report
Generated from MCA filings & public recordsSupriyalifescience is assessed as Low Risk with a Trust Score of 78/100. Supriyalifescience is an active public limited indian non-government company incorporated in 2008, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 22 Nov 2026 from the latest processed filings. Supriya Lifescience Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Liabilities ≈ 38% EBITDA - serviceable.
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A2).
Charges position: 6 open ( 48.0 cr ) · 39 satisfied ( 12.5 cr ).
| Lender | Charges | Amount |
|---|---|---|
| Others | 11 | 48.0 cr |
| Idbi Trusteeship Services Limited | 1 | 48.0 cr |
| The Saraswat Cooperative Bank Ltd | 18 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
| The Saraswat Co-Op Bank Ltd | 5 | 48.0 cr |
| Development Credit Bank Limited | 3 | 48.0 cr |
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (198 disclosure(s)).
- 1 active GST registration(s).
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SMITA SATISH WAGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KOTHANDARAMAN HARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NEELAM YASHPAL ARORA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sunil Subhash Bhagwat | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHIVANI SATISH WAGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SALONI SATISH WAGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANISH ISHWARLAL PANCHAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KRISHNA RAGHUNATHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SATISH WAMAN WAGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BALASAHEB GULABRAO SAWANT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GANAPATHI DADASAHEB YADAV | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KRISHNA RAGHUNATHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Prachi Suhas Sathe | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 13 directors on the board.
- KRISHNA RAGHUNATHAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2025 annual returnPromoters hold a majority stake - exact percentages are part of the full report.
Key managerial personnel: SMITA SATISH WAGH (Whole-time director) · SHIVANI SATISH WAGH (Managing Director) · SALONI SATISH WAGH (Managing Director) · KRISHNA RAGHUNATHAN (CFO) · SATISH WAMAN WAGH (Whole-time director) · BALASAHEB GULABRAO SAWANT (Whole-time director) · KRISHNA RAGHUNATHAN (CFO)
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 90 · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 6 open charge(s) already registered.
- Compliance gaps should be priced into terms.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Klr Products Limited | U24239TG2003PLC041387 | Hyderabad, Telangana, India |
| Fineotex | L24100MH2004PLC144295 | Mumbai, Maharashtra, India |
| Clariant | L24110MH1956PLC010806 | Thane, Maharashtra, India |
| Yasho Industries | L74110MH1985PLC037900 | Mumbai, Maharashtra, India |
| Anthea Aromatics | U24100MH2008PTC179684 | Navi Mumbai, Maharashtra, India |
| Kokuyocamlin | L24223MH1946PLC005434 | Mumbai, Maharashtra, India |
| Aarti Surfactants | L24100MP2018PLC067037 | Dhar, Madhya Pradesh, India |
| Neogenchem | L24200MH1989PLC050919 | Thane, Maharashtra, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Supriyalifescience before audits and certifications: compliance score 66/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Supriyalifescience: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Supriyalifescience - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Supriyalifescience pays its suppliers before you extend credit terms.
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Supriyalifescience - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Supriyalifescience an active company?
Supriyalifescience has MCA status “Active” with a compliance score of 66/100 (Moderate).
Is Supriyalifescience financially healthy?
Supriyalifescience has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Supriyalifescience?
Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Supriyalifescience?
Promoters hold a majority stake - exact percentages are in the full report. 13 active director(s) are on record.
Does Supriyalifescience have loans or charges against its assets?
6 open charge(s) are registered against its assets, and 39 earlier charge(s) stand satisfied.
Is Supriyalifescience up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 66/100 (Moderate).
Is it risky to lend to Supriyalifescience?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.